Peter de Nully Brown

Research interests

Publications

• Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)33008-9

• Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

  The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)32984-2

• TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy

  Blood · 2017 · https://doi.org/10.1182/blood-2017-04-779736

• Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study

  Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2014.59.2782

• Cerebrospinal Fluid Secretion by the Choroid Plexus

  Physiological Reviews · 2013 · https://doi.org/10.1152/physrev.00004.2013

• Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography–Staged Treatment-Naive Patients With Hodgkin Lymphoma

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2012.42.4036

• Nordic MCL 2 trial update: six‐year follow‐up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem‐cell support: still very long survival but late relapses do occur

  British Journal of Haematology · 2012 · https://doi.org/10.1111/j.1365-2141.2012.09174.x

• Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.40.2719

• CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

  The Lancet Oncology · 2011 · https://doi.org/10.1016/s1470-2045(11)70235-2

• Biallelic Mutation of BEST1 Causes a Distinct Retinopathy in Humans

  The American Journal of Human Genetics · 2008 · https://doi.org/10.1016/j.ajhg.2007.08.004

• Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

  Blood · 2008 · https://doi.org/10.1182/blood-2008-03-147025

• Molecular mechanisms of cerebrospinal fluid production

  Neuroscience · 2004 · https://doi.org/10.1016/j.neuroscience.2004.07.003

• Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial

  British Journal of Cancer · 2002 · https://doi.org/10.1038/sj.bjc.6600310

• A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer

  British Journal of Cancer · 2002 · https://doi.org/10.1038/sj.bjc.6600446

• Marimastat as First-Line Therapy for Patients With Unresectable Pancreatic Cancer: A Randomized Trial

  Journal of Clinical Oncology · 2001 · https://doi.org/10.1200/jco.2001.19.15.3447

• Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors

  Chemical Reviews · 1999 · https://doi.org/10.1021/cr9804543

• Matrix metalloproteinases

  British journal of surgery · 1997 · https://doi.org/10.1002/bjs.1800840206

• Matrix metalloproteinases

  British journal of surgery · 1997 · https://doi.org/10.1046/j.1365-2168.1997.02719.x

• Matrix metalloproteinase inhibition: A review of anti-tumour activity

  Annals of Oncology · 1995 · https://doi.org/10.1093/oxfordjournals.annonc.a059091

• Inhibition of Angiogenesis and Murine Hemangioma Growth by Batimastat, a Synthetic Inhibitor of Matrix Metalloproteinases

  JNCI Journal of the National Cancer Institute · 1995 · https://doi.org/10.1093/jnci/87.4.293

• Association Between Expression of Activated 72-Kilodalton Gelatinase and Tumor Spread in Non-Small-Cell Lung Carcinoma

  JNCI Journal of the National Cancer Institute · 1993 · https://doi.org/10.1093/jnci/85.7.574

• Role of the alpha v beta 3 integrin in human melanoma cell invasion.

  Proceedings of the National Academy of Sciences · 1992 · https://doi.org/10.1073/pnas.89.5.1557

• Tumor Cell Invasion Inhibited by TIMP-2

  JNCI Journal of the National Cancer Institute · 1991 · https://doi.org/10.1093/jnci/83.11.775

• Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues.

  Journal of Biological Chemistry · 1990 · https://doi.org/10.1016/s0021-9258(18)77438-3

• Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.

  PubMed · 1990

Current projects

No projects listed.